Amy Rabourn
Treasurer presso OCUPHIRE PHARMA, INC.
Patrimonio netto: 11 823 $ in data 30/04/2024
Posizioni attive di Amy Rabourn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Treasurer | - | - |
| Comptroller/Controller/Auditor | 11/11/2020 | - | |
| Direttore Finanziario/CFO | 01/12/2019 | 12/02/2024 |
Storia della carriera di Amy Rabourn
Precedenti posizioni note di Amy Rabourn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/12/2014 | 01/12/2019 |
Formazione di Amy Rabourn
| University of Michigan | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Director of Finance/CFO | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
- Borsa valori
- Insiders
- Amy Rabourn
- Esperienza